Early Life
Ramesh C. Juneja was born on July 28, 1955, and hails from Meerut, Uttar Pradesh, India. He came from a middle-class family. After completing his science graduation, Juneja began his career in the pharmaceutical industry in 1974 as a medical representative with KeePharma Ltd. He then joined Lupin Limited in 1975 and worked there as a first-line manager for about 8 years.
Rise to Success
In 1995, Ramesh Juneja co-founded Mankind Pharma with his younger brother Rajeev Juneja. The company started with an initial investment of ₹50 lakhs and a team of 25 medical representatives. Under his leadership, Mankind Pharma focused on providing affordable medicines, which resonated with the Indian market. The company quickly grew, becoming the fourth-largest pharmaceutical company in India. Mankind Pharma launched an IPO in April 2023, with the stock listed at a 20% premium.
Key Business Strategies
Key strategies include a focus on low-cost generics, making medicines accessible to a wider audience, and the creation of popular brands such as Manforce, Prega News, and Unwanted 72. Strategic acquisitions, such as the full acquisition of Bharat Serums and Vaccines (BSV) in October 2024, have expanded Mankind Pharma's product portfolio and market reach.
Philanthropy
Ramesh Juneja is known for his philanthropic contributions to healthcare and education, supporting various initiatives aimed at improving access to quality healthcare and promoting education among underprivileged communities.